Close Menu

NEW YORK (GenomeWeb) – Pacific Biosciences has launched a certified service provider program and has also partnered with three informatics firms to provide data analysis on the RS II, the firm said today.

The CSP program is a global network of service providers that have been validated to provide sequencing services on the RS II system. The first certified providers are DNA Link, GATC Biotech, McGill University and Genome Québec Innovation Center, Takara Bio, Washington State University's Molecular Biology and Genomics Core, and the Arizona Genomics Institute.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Elsevier and a Norwegian consortium come to a "read-and-publish" agreement, according to Nature News.

Researchers in France have explored the genetic history of the blue cheese mold, Forbes reports.

The South China Morning Post reports eight genetic testing firms in Hong Kong are under scrutiny for potentially misleading consumers.

In Science this week: platform to diagnose genetic disease in children, lung disease-causing genetic mutation corrected in mice, and more.

Apr
30
Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

May
01
Sponsored by
Illumina

This webinar will discuss the benefits of virus-specific target capture combined with next-generation sequencing (NGS) to identify viral infections and conduct comprehensive genomic and transcriptomic interrogation.

May
07
Sponsored by
Agilent

This webinar will discuss the implementation of an enterprise-wide clinical genomics platform that is shared across 10 hospitals and research organizations in the Australian State of Victoria.

May
08
Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.